期刊
CURRENT ONCOLOGY REPORTS
卷 12, 期 6, 页码 349-351出版社
SPRINGER
DOI: 10.1007/s11912-010-0121-4
关键词
Maintenance chemotherapy; Antineoplastic therapy; Paclitaxel; Erlotinib; Pemetrexed
类别
Individual randomized phase 3 trials and meta-analyses of previously published studies have provided support for the general concept of the clinical utility of extending the duration of antineoplastic drug therapy in an effort to prolong (maintain) a favorable clinical state. This commentary briefly reviews data from several of these reports.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据